Skip to main content
Fitness Consequences of Plasmodium falciparum pfmdr1 Polymorphisms Inferred from Ex Vivo Culture of Ugandan Parasites.
In vitro and in vivo antimalarial efficacies of optimized tetracyclines.
Novel potent metallocenes against liver stage malaria.
In vitro activity of antiretroviral drugs against Plasmodium falciparum.
Design and evaluation of primaquine-artemisinin hybrids as a multistage antimalarial strategy.
Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.
In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda.
Discordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparum.
Population pharmacokinetics of lamivudine in human immunodeficiency virus-exposed and -infected infants.
Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda.